Lincoln Electric Schedules Webcast for Fourth Quarter and Full Year 2023 Results
CLEVELAND, Jan. 18, 2024 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will […]
Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) — Aimei Health Technology Co., Ltd. (“Aimei”) announced today that, commencing January 22, […]
GOGL – Changes to the Board composition
Golden Ocean Group Ltd (“GOGL” or “the Company”) announces the appointment of Mr. Cato Stonex as Director. Mr. Stonex has […]
OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results
RED BANK, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) — OceanFirst Financial Corp. (NASDAQ:“OCFC”) (the “Company”), the holding company for OceanFirst […]
Lamar Advertising Announces Tax Reporting Information For 2023 Distributions on Common Stock
BATON ROUGE, La., Jan. 18, 2024 (GLOBE NEWSWIRE) — Lamar Advertising Company (“Lamar”) (Nasdaq: LAMR) today announced certain year-end federal […]
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in […]
Fidelity D & D Bancorp, Inc. First Quarter 2024 Dividend
DUNMORE, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) — The Board of Directors of Fidelity D & D Bancorp, Inc. (NASDAQ: […]
South Plains Financial, Inc. Declares Quarterly Cash Dividend
LUBBOCK, Texas, Jan. 18, 2024 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains”), the parent company of City […]
Snap One Launches Control4 Connect & Control4 Assist to Elevate the Customer Experience and Create New Recurring Revenue Opportunities for Partners
CHARLOTTE, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) — In a significant move to evolve the core business model of the […]
NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
BELTSVILLE, Md., Jan. 18, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing […]
